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Purpose: Glaucoma is a progressive optic neuropathy that may lead to blindness. Reducing 
intraocular pressure (IOP) is the only known treatment to slow progression in glaucoma. IOP 
can be reduced by pharmaceutical treatment, laser and surgery. The aim of the present study was 
to assess predictive factors of success after selective laser trabeculoplasty (SLT) treatment.
Methods: We used a retrospective chart review of eyes that underwent SLT between January 1, 
2005 and December 31, 2005. The dependent variable was time to failure after SLT treatment. 
Failure after SLT was defined as any changes in the medical treatment, and/or a new SLT treatment 
was performed and/or the patient was sent for surgery. All patients were treated with 90° SLT. 
A multivariate regression analysis was performed to assess correlation between time to failure 
after SLT and age, gender, IOP before treatment, number of medications used, SLT number, 
amount of spots, laser energy used, grade of angle, pigmentation and diagnosis.
Results: 120 eyes of 120 patients were identified. The average time to failure after SLT was 
18 months. The predictive factors identified were: age, IOP before SLT and dose.
Conclusion: Predictive factors identified in our study were high baseline IOP, age and amount 
of laser energy used. Our study confirms previous results about baseline IOP as a predictive 
factor.
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Introduction
Glaucoma is a progressive neuropathy localized in the optic nerve and it is among the 
leading causes of blindness worldwide.1 Reducing intraocular pressure (IOP) seems to 
be the only treatment that slows progression in glaucoma. There are several methods 
to reduce IOP: pharmaceutical treatment, laser treatment and surgery. In the Glaucoma 
Laser Trial Follow-up study, after 7 years of follow-up, patients who had undergone 
argon laser trabeculoplasty (ALT) had lower IOP than patients on pharmaceutical 
treatment.2,3 However, in selective laser trabeculoplasty (SLT) there is still not suf-
ficient evidence to determine the effectiveness of SLT compared to medication. SLT 
appears to be less costly than current pharmaceutical treatment.4
ALT was introduced about 35 years ago and involves the use of a blue/green argon 
laser (major wavelength peaks at 488 nm and 514 nm) to treat the outer part of the 
trabecular meshwork and thereby improve aqueous outflow and thus reduce IOP. SLT 
uses a 532-nm frequency-double q-switched nd:YAG laser that delivers a low-energy, 
large spot, very brief pulse to selectively target cells of the trabecular meshwork. This 
“gentler” laser application is thought to stimulate the pigmented trabecular meshwork 





reducing the IOP is not known.5 As SLT is a relatively new 
treatment alternative it is important for clinicians to assess 
the probability of successful IOP reduction. Assessment of 
predictive factors may determine which patients have a greater 
probability of achieving acceptable IOP reduction. The aim of 
the present study was to identify predictive factors of success 
in SLT treatment.
Materials and methods
This was a retrospective chart review of patients treated from 
January 1, 2005 till December 31, 2005. Inclusion criteria 
were open-angle glaucoma (primary open angle, pseudoex-
foliation or pigmentary glaucoma) and ocular hypertensive 
(OHT) patients, older than 18 years, who were uncontrolled 
on pharmaceutical therapy and who had been given SLT 
treatment. Patients who could not be followed for at least 
4 years were excluded.
Data recorded from each patient included age, sex, type 
of glaucoma, glaucoma medications and the SLT protocol 
(number of spots and laser power settings). The IOP values 
before and after SLT were also registered. All patients con-
tinued with the same pharmaceutical treatment after SLT.
The SLT protocol consisted of treatment that was per-
formed in 90° with the SLT Solo laser (Ellex, Adelaide, 
  Australia) using between 25 and 30 spots applied to the 
trabecular meshwork. The energy level ranged from 0.6 
to 1.0 mJ. All patients were treated by the same physician 
(E.C.).   Apraclonidine was instilled once after SLT treatment. 
Follow-up IOP measurements were obtained at least 1, 6, 12, 
24 and 48 months after SLT treatment. The authors followed 
the Tenets of the Declaration of Helsinki.
The main outcome variable analyzed was the time to 
failure after SLT treatment. Failure after SLT was defined 
as any one or more of the following: change in the pharma-
ceutical treatment; performance of a further SLT treatment; 
the patient being sent for surgery.
When two eyes of the same patient were treated, one eye 
was chosen at random for analysis. All data were entered into a 
database. Multivariate regression analysis was performed to see 
significant correlations between the variables (P = 0.05). The 
general purpose of multiple regression analysis is to learn more 
about the relationship between several independent or predictor 
variables and a dependent or criterion variable. Independent 
variables: age, gender, IOP before treatment, number of medi-
cations used, SLT number, amount of spots, energy used, grade 
of angle (0–4), pigmentation (0–3) and diagnosis. Dependent 
variable: time to failure after SLT   treatment. Statistical soft-
ware: STATA (Statacorp, College Station, TX).
Results
In all, 120 eyes of 120 patients were identified during the 
defined time period. The baseline characteristics of the 
sample are given in Table 1.
The multivariate analysis showed a significant negative 
correlation between age and time to failure (P = 0.015). 
With increasing age the time to failure was shortened. The 
IOP before SLT treatment also showed a significant nega-
tive correlation with time to failure after SLT (P # 0.001), 
meaning that with higher IOP before treatment, time to failure 
was shortened.
Laser energy used and time to failure showed a slight 
significant positive correlation (P = 0.047). With increasing 
energy, there was a longer time to failure after SLT. See 
Table 2.
Discussion
Selective laser trabeculoplasty is a commonly accepted 
therapy for lowering IOP. The present study aims to answer 
the question of factors that can predict success of SLT over 
a longer period of time (4 years). Predictive factors have 
been reported by Gracner et al6 showing a negative correla-
tion between successful SLT and the grade of trabecular 
meshwork pigmentation and diabetes. The authors did not 
find any significant correlations between successful SLT 
and baseline IOP, age, sex, hypertension, family history of 
glaucoma, previous anterior segment surgery, laser energy 
used and local antiglaucoma therapy. This study found that 
SLT efficacy is positively associated with IOP elevation 
before laser treatment. This is consistent with Hodge et al7 
Table 1 Baseline characteristics of the subjects included in the 
study
Characteristic
Age (sD) 76.5 (11.8) years
gender 75% women
iOP before sLT (mm hg) (sD) 24.7 (4.6)
Number of SLT procedures undergone:
  sLT 1 (%) 74 (62)
  sLT 2 (%) 38 (32)
  sLT 3 (%) 5 (4)
  sLT 4 (%) 3 (2)
Average number of spots per eye (sD) 26.9 (4.8)
Average dose per eye (mJ) (sD) 0.88 (0.11)
Average anterior chamber (0–4) (sD) 3.8 (0.49)
Average pigmentation (0–3) (sD) 0.77 (0.66)
Diagnosis:
  exfoliative glaucoma (%) 73 (61)
  Primary open angle glaucoma (%) 34 (28)
  Ocular hypertension (%) 9 (7.5)





who reported that SLT success was significantly predicted 
by baseline IOP but not by age, sex, other glaucoma risk fac-
tors, type of open angle glaucoma or by degree of trabecular 
meshwork pigmentation. Also this study is consistent with 
Mao et al8 who reported a positive association between laser 
efficacy and IOP before SLT treatment. Our results are also 
in line with the results presented by George et al9 who found 
that baseline IOP was the only preoperative predictive factor 
for response to ALT and non overlapping SLT.
We found a significant correlation between successful 
SLT and age, baseline IOP and amount of laser energy 
delivered. Comparisons among studies are always difficult 
to perform due to different populations studied, different 
time periods, how failure was defined, etc. The fact that 
Gracner et al6 did not find a significant correlation between 
baseline IOP and success might be due to different levels 
of IOP in the patients included. In our study the mean level 
of baseline IOP was 24.7 mmHg meanwhile Gracner et al6 
included patients with IOP 22.5 mmHg. Mao et al8 found a 
positive correlation between IOP reduction and IOP before 
SLT treatment including patients with a baseline IOP of 
26 mm Hg. Lower baseline pressures have been associated 
with a reduced pressure-lowering effect.10
A significant negative correlation between age and time 
to failure (P = 0.015) was found in this study. This means 
that with increasing age the time to failure was shortened. 
The mean age of the included patients in our study was quite 
high (76.5 years). SLT’s IOP reduction mechanisms are 
still unknown but it has been postulated that activation of 
prostaglandins can have certain effects.11 Probably chemical 
factors are reduced due to increased age, thus shortening the 
time IOP reduction is maintained after SLT. Another possible 
explanation could be the severity of the existing glaucoma. 
Older patients tend to have more advanced glaucoma, so the 
physicians who examined those patients after SLT treatment 
may not have been satisfied with the IOP reduction gained 
and changed the treatment, thus increasing the number of 
cases classified as “failure.” In comparable studies, younger 
patients were included. Gracner et al6 included patients that 
were 70.3 years meanwhile Hodge et al7 included patients 
that were 69.08 years. Mao et al8 included patients that were 
63 years. None of these studies found a significant correlation 
between age and success after SLT treatment.
The amount of laser energy delivered during SLT treat-
ment was identified as a predictive factor in our study. Laser 
energy used and time to failure showed a slight significant 
positive correlation (P = 0.047): with increasing energy, 
there was a longer time to failure after SLT. Gracner et al,6 
Hodge et al7 and Mao et al8 did not find any correlation 
between laser energy used and success after SLT treatment. 
The average total laser energy used by Gracner et al6 was 
around 40 mJ. Hodge et al7 used an energy around 44 mJ 
while Mao et al8 reported an energy of 41 mJ. The average 
total energy used in our study was 23.67 mJ. A particular 
point to be considered is that the laser protocol used in our 
study treated just 90° of the trabecular meshwork making our 
results difficult to compare with previous published results. 
It is possible to speculate that SLT treatment in 180° would 
decrease the failure rates.
Our study is limited by its retrospective design. One issue 
to be considered is selection bias. All patients were treated at 
a tertiary referral center where the patient population tends 
to have more advanced glaucoma. Severity of glaucoma 
may have been a confounding factor; however, this was not 
directly evaluated in this study. Ethnicity was not recorded 
in the medical journals of the patients included in the study, 
therefore ethnicity could not be evaluated in the study. It is 
reasonable to assume that the majority of the patients were 
Caucasians. Another possible selection bias is the high per-
centage of pseudoexfoliative glaucoma patients included 
in the study (61%). Exfoliation is a common problem in 
Sweden. We did not find a correlation between different 
diagnosis and time to failure after SLT treatment. These 
results are consistent with Gracner12 who found no difference 
in SLT results comparing capsular glaucoma and primary 
open-angle glaucoma. Further prospective clinical cohort 
studies are needed to confirm these results.
Predictive factors identified in our study were high 
baseline IOP, age and amount of laser energy used. Our study 
confirms previous results about baseline IOP as a predictive 
factor. IOP before SLT treatment seems to be a predictive 
factor for success even when SLT treatment was delivered 
Table 2 Multivariate regression analysis: time to failure depend-
ent variable
Variables Test value (T) Probability (P)
Age 2.48 0.015 (*)
gender 0.57 0.571
sLT number 0.59 0.557
number of spots 1 0.318
Laser energy 2.01 0.047 (*)
grade of angle (0–iV) 0.06 0.95
Pigmentation (0–iii) 0.41 0.686
iOP before sLT 3.75 ,0.001 (*)
Diagnose 0.56 0.57
number of medications 0.7 0.866
Note: Significant correlations are marked (*).
Abbreviations: sLT, selective laser trabeculoplasty; iOP, intraocular pressure.Clinical Ophthalmology
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in 90°. As a general recommendation coming from the study 
it is possible to say that SLT treatment works well among 
patients with IOP around 24–26 mmHg, while lower baseline 
pressures have been associated with a reduced pressure-
lowering effect. Further studies with longer follow-up and 
bigger sample sizes are needed.
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